Article
Tumor cell-intrinsic stress states drive sensitivity to CAR T cell-therapy in pancreatic cancer
2025-07-29
Abstract excerpt
Chimeric antigen receptor (CAR) T cell therapy has transformed the treatment of hematologic cancers, but has shown limited efficacy in solid tumors, including pancreatic ductal adenocarcinoma (PDAC). The cellular and molecular factors that influence CAR T cell therapy response remain largely unknown. By integrating modular in vivo CRISPR screens with single cell genomics and immunocompetent orthotopic models of P...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c545131d-3646-59fe-b3b8-f893967f8f14
- DOI
- 10.1101/2025.07.24.666408
